Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Analyzing medical and recreational cannabis state laws – a pharmacological perspective
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: FRANSON, Kari (University of Colorado, Skaggs School of Pharmacy & Pharmaceutical Sciences)
- Co-author(s): Kari L Franson
Fiona H. Wong: Skaggs School of Pharmacy & Pharmaceutical Sciences, University of Colorado, Aurora, United States
BackgroundThere are 29 states and the District of Columbia that have legalized medical, and 8 states and DC that have legalized recreational cannabis. Not all state legislatures have considered pharmacological evidence when creating their laws.
MethodsWe analyzed medical and recreational cannabis laws in these categories: age of use, approved.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019